EXONEUROGENESIS

What this means for you

This application is over — abandoned 08 Aug 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88757965

Mark type

Stylized text

Filed

14 Jan 2020

Published for opposition

10 Nov 2020

Abandoned

08 Aug 2022

Attorney of record

Christina M. Licursi

Goods and services

• Class 042 — Scientific and technological services: scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; pharmaceutical preparations for the treatment of cancer and immune system related diseases

Owner

• Cygnal Therapeutics, Inc., Cambridge, MA, US
• Cygnal Therapeutics, Inc., Cambridge, MA, US

Prosecution history

• 08 Aug 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 08 Aug 2022 — ABANDONMENT - NO USE STATEMENT FILED
• 06 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 04 Jan 2022 — SOU EXTENSION 2 GRANTED
• 04 Jan 2022 — SOU EXTENSION 2 FILED
• 04 Jan 2022 — SOU TEAS EXTENSION RECEIVED
• 06 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 03 Jul 2021 — SOU EXTENSION 1 GRANTED
• 03 Jul 2021 — SOU EXTENSION 1 FILED
• 03 Jul 2021 — SOU TEAS EXTENSION RECEIVED
• 26 Mar 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 26 Mar 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 26 Mar 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 05 Jan 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 10 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED